Clinical promise and investment implications

Weight-loss drugs like Ozempic and Wegovy are reshaping healthcare — and potentially the economy.

Dr Zac Turner explains to Sean Aylmer how GLP-1 drugs work, what we’re still learning about their long-term effects, why the next generation matters, and how these medications may go far beyond weight loss.

Find out more: https://fearandgreed.com.au/

See omnystudio.com/listener for privacy information.